These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
75 related articles for article (PubMed ID: 1818954)
1. Effect of the angiotensin II receptor antagonist MK 954 on the angiotensin II-induced increase in free cytosolic Ca2+ and growth in vascular smooth muscle cells. Sachinidis A; Görg A; Ko Y; Wieczorek AJ; Düsing R; Vetter H J Hypertens Suppl; 1991 Dec; 9(6):S226-7. PubMed ID: 1818954 [No Abstract] [Full Text] [Related]
2. Losartan inhibits the angiotensin II-induced stimulation of the phosphoinositide signalling system in vascular smooth muscle cells. Ko Y; Görg A; Appenheimer M; Wieczorek AJ; Düsing R; Vetter H; Sachinidis A Eur J Pharmacol; 1992 Oct; 227(2):215-9. PubMed ID: 1426030 [TBL] [Abstract][Full Text] [Related]
3. Chronic blockade of AT2-subtype receptors prevents the effect of angiotensin II on the rat vascular structure. Levy BI; Benessiano J; Henrion D; Caputo L; Heymes C; Duriez M; Poitevin P; Samuel JL J Clin Invest; 1996 Jul; 98(2):418-25. PubMed ID: 8755652 [TBL] [Abstract][Full Text] [Related]
4. Platelet-derived growth factor and angiotensin II cause increases in cytosolic free calcium by different mechanisms in vascular smooth muscle cells. Roe MW; Hepler JR; Harden TK; Herman B J Cell Physiol; 1989 Apr; 139(1):100-8. PubMed ID: 2708448 [TBL] [Abstract][Full Text] [Related]
5. Angiotensin II-1 receptors mediate both vasoconstrictor and hypertrophic responses in rat aortic smooth muscle cells. Chiu AT; Roscoe WA; McCall DE; Timmermans PB Receptor; 1991; 1(3):133-40. PubMed ID: 1843203 [TBL] [Abstract][Full Text] [Related]
6. The angiotensin type 2 receptor mediates RNA synthesis in A10 vascular smooth muscle cells. Saward L; Zahradka P J Mol Cell Cardiol; 1996 Mar; 28(3):499-506. PubMed ID: 9011633 [TBL] [Abstract][Full Text] [Related]
7. Angiotensin II down-regulates the vascular smooth muscle AT1 receptor by transcriptional and post-transcriptional mechanisms: evidence for homologous and heterologous regulation. Lassègue B; Alexander RW; Nickenig G; Clark M; Murphy TJ; Griendling KK Mol Pharmacol; 1995 Oct; 48(4):601-9. PubMed ID: 7476884 [TBL] [Abstract][Full Text] [Related]
8. A long-term receptor stimulation is requisite for angiotensin II-dependent DNA synthesis in vascular smooth muscle cells from spontaneously hypertensive rats. Itazaki K; Hara M; Itoh N; Fujimoto M Eur J Pharmacol; 1995 Nov; 291(3):417-25. PubMed ID: 8719428 [TBL] [Abstract][Full Text] [Related]
9. Angiotensin II induces apoptosis of adult ventricular myocytes in vitro. Kajstura J; Cigola E; Malhotra A; Li P; Cheng W; Meggs LG; Anversa P J Mol Cell Cardiol; 1997 Mar; 29(3):859-70. PubMed ID: 9152847 [TBL] [Abstract][Full Text] [Related]
11. Effects of captopril, losartan, and nifedipine on cell hypertrophy of cultured vascular smooth muscle from hypertensive Ren-2 transgenic rats. Peiró C; Llergo JL; Angulo J; López-Novoa JM; Rodríguez-López A; Rodríguez-Mañas L; Sánchez-Ferrer CF Br J Pharmacol; 1997 Aug; 121(7):1438-44. PubMed ID: 9257925 [TBL] [Abstract][Full Text] [Related]
12. Acute myocardial and vascular responses to specific angiotensin II antagonism in the spontaneously hypertensive rat. Cody RJ; Binkley PF; Haas GJ; Brown DM Am J Hypertens; 1995 May; 8(5 Pt 1):500-8. PubMed ID: 7662227 [TBL] [Abstract][Full Text] [Related]
13. EXP3174, a metabolite of losartan (MK 954, DuP 753) is more potent than losartan in blocking the angiotensin II-induced responses in vascular smooth muscle cells. Sachinidis A; Ko Y; Weisser P; Meyer zu Brickwedde MK; Düsing R; Christian R; Wieczorek AJ; Vetter H J Hypertens; 1993 Feb; 11(2):155-62. PubMed ID: 8385175 [TBL] [Abstract][Full Text] [Related]
14. Angiotensin II receptors in rabbit vascular grafts. Hausner EA; Turner MJ; Trzaskos JM; Herblin WF Biochem Biophys Res Commun; 1993 Jan; 190(1):27-32. PubMed ID: 8422252 [TBL] [Abstract][Full Text] [Related]
15. Cardiovascular hypertrophy in one-kidney, one clip renal hypertensive rats: a role for angiotensin II? O'Sullivan JB; Black MJ; Bertram JF; Bobik A J Hypertens; 1994 Oct; 12(10):1163-70. PubMed ID: 7836732 [TBL] [Abstract][Full Text] [Related]
16. Prevention of angiotensin II induced myocyte necrosis and coronary vascular damage by lisinopril and losartan in the rat. Kabour A; Henegar JR; Devineni VR; Janicki JS Cardiovasc Res; 1995 Apr; 29(4):543-8. PubMed ID: 7796449 [TBL] [Abstract][Full Text] [Related]
17. Alterations in vascular structure and function after short-term losartan treatment in spontaneously hypertensive rats. Soltis EE J Pharmacol Exp Ther; 1993 Aug; 266(2):642-6. PubMed ID: 8355197 [TBL] [Abstract][Full Text] [Related]
18. Effects of BAY 10-6734 (Embusartan), a new angiotensin II type I receptor antagonist, on vascular smooth muscle cell growth. Iouzalen L; Stepien O; Marche P J Pharmacol Exp Ther; 1999 Apr; 289(1):181-7. PubMed ID: 10087002 [TBL] [Abstract][Full Text] [Related]
19. Angiotensin-II-induced cell hypertrophy: potential role of impaired proteolytic activity in cultured LLC-PK1 cells. Ling H; Vamvakas S; Schaefer L; Schnittler HJ; Schaefer RM; Heidland A Nephrol Dial Transplant; 1995; 10(8):1305-12. PubMed ID: 8538919 [TBL] [Abstract][Full Text] [Related]
20. Blunted attenuation of angiotensin II-mediated Ca2+ transients by insulin in cultured unpassaged vascular smooth muscle cells from spontaneously hypertensive rats. Touyz RM; Tolloczko B; Schiffrin EL Am J Hypertens; 1995 Feb; 8(2):104-12. PubMed ID: 7755938 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]